Menu
Menu
Inflectra (Infliximab-dyyb) is a biosimilar of Remicade. It is indicated for the treatment of Crohn’s Disease, pediatric Crohn’s Disease, Ulcerative Colitis, Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis and Plaque Psoriasis. Inflectra is administered as an intravenous infusion.
Inflectra infusions are generally administered every six to eight weeks, and infusions are given over a period of about 2 hours. Infusions may be given more frequently at the start of therapy, known as the induction period. Sometimes pre-medications are administered prior to infusions, such as steroids, benadryl, or tylenol. An observation time may be required after your infusion.
The most common side effects of Inflectra include respiratory infections, cough, stomach pain and headache.
Inflectra can lower the ability of your immune system to fight infections.
Your doctor should test you for tuberculosis and hepatitis B before starting Inflectra.
We offer expert infusion therapy without the hassle or cost of the hospital. We employ highly trained medical staff that work with health insurance companies & physicians to provide our patients with convenient care.
At Omega Health Clinics, we’re committed to offering affordable treatment, with upfront pricing and no hidden costs. Here’s how we make it happen.
